Eltoukhy Helmy's most recent trade in Guardant Health Inc was a trade of 2,049,517 Common Stock done . Disclosure was reported to the exchange on Dec. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,049,517 | 2,049,517 (2%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2025 | 2,049,517 | 13,209 (0%) | 2% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 2,073,514 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 23,997 | 95,989 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 31 Dec 2025 | 10,788 | 2,062,726 (2%) | 0% | 102.1 | 1,101,886 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 4,815 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 4,815 | 2,051,958 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 31 Dec 2025 | 2,441 | 2,049,517 (2%) | 0% | 102.1 | 249,324 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.80 per share. | 15 Dec 2025 | 83,945 | 2,053,763 (2%) | 0% | 103.8 | 8,713,592 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 104.02 per share. | 15 Dec 2025 | 6,620 | 2,047,143 (2%) | 0% | 104.0 | 688,628 | Common Stock |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 23,997 | 2,149,870 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 23,997 | 119,986 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.65 per share. | 30 Sep 2025 | 12,162 | 2,137,708 (2%) | 0% | 62.6 | 761,949 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 4,814 | 2,128,313 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 4,814 | 4,815 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.48 per share. | 30 Sep 2025 | 2,440 | 2,125,873 (2%) | 0% | 62.5 | 152,451 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.44 per share. | 09 Sep 2025 | 294,723 | 2,128,776 (2%) | 0% | 59.4 | 17,519,720 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.93 per share. | 09 Sep 2025 | 5,277 | 2,123,499 (2%) | 0% | 59.9 | 316,275 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 23,997 | 143,983 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 23,997 | 2,435,661 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 30 Jun 2025 | 12,162 | 2,423,499 (2%) | 0% | 50.7 | 616,735 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 4,815 | 9,629 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 4,815 | 2,414,105 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.04 per share. | 30 Jun 2025 | 2,441 | 2,411,664 (2%) | 0% | 52.0 | 127,030 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 23,998 | 2,421,453 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 23,998 | 167,980 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 31 Mar 2025 | 12,163 | 2,409,290 (2%) | 0% | 42.5 | 516,563 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,814 | 14,444 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 4,814 | 2,399,895 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.60 per share. | 31 Mar 2025 | 2,440 | 2,397,455 (2%) | 0% | 42.6 | 103,944 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 68,769 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 68,769 | 2,429,934 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 14 Mar 2025 | 34,853 | 2,395,081 (2%) | 0% | 42.9 | 1,494,845 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 116,010 | 116,010 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 19,258 | 19,258 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 94,555 | 191,978 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 94,555 | 2,404,474 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 31 Dec 2024 | 43,309 | 2,361,165 (2%) | 0% | 30.6 | 1,323,090 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 11,462 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 11,462 | 2,315,728 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 31 Dec 2024 | 5,809 | 2,309,919 (2%) | 0% | 30.6 | 177,465 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 11,461 | 11,462 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 11,461 | 2,310,075 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.94 per share. | 30 Sep 2024 | 5,809 | 2,304,266 (2%) | 0% | 22.9 | 133,258 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 11,462 | 22,923 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 11,462 | 2,304,423 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 30 Jun 2024 | 5,809 | 2,298,614 (2%) | 0% | 28.9 | 167,764 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 03 May 2024 | 200,000 | 2,292,961 (2%) | 0% | 4.2 | 836,000 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 200,000 | 511,612 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 11,461 | 34,385 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 11,461 | 2,097,470 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.63 per share. | 31 Mar 2024 | 4,509 | 2,092,961 (2%) | 0% | 20.6 | 93,021 | Common Stock |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 18 Mar 2024 | 1,130,382 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 286,533 | 286,533 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 45,846 | 45,846 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 365,775 | 0 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Eltoukhy Helmy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 164,716 | 164,716 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 164,288 | 164,288 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 21 Jul 2023 | 36,771 | 2,086,009 (2%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 26.33 per share. | 14 Mar 2023 | 84,452 | 2,040,638 (2%) | 0% | 26.3 | 2,223,908 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 26.15 per share. | 14 Mar 2023 | 8,600 | 2,049,238 (2%) | 0% | 26.2 | 224,928 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 97.90 per share. | 19 Nov 2021 | 37,591 | 1,889,277 (2%) | 0% | 97.9 | 3,680,317 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 93.04 per share. | 19 Nov 2021 | 26,394 | 1,931,186 (2%) | 0% | 93.0 | 2,455,811 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 96.83 per share. | 19 Nov 2021 | 14,900 | 1,956,086 (2%) | 0% | 96.8 | 1,442,774 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 98.75 per share. | 19 Nov 2021 | 12,409 | 1,901,686 (2%) | 0% | 98.8 | 1,225,446 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 95.50 per share. | 19 Nov 2021 | 5,000 | 1,941,186 (2%) | 0% | 95.5 | 477,500 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 94.00 per share. | 19 Nov 2021 | 5,000 | 1,936,186 (2%) | 0% | 94 | 470,000 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 92.23 per share. | 19 Nov 2021 | 3,106 | 1,904,792 (2%) | 0% | 92.2 | 286,481 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 98.00 per share. | 19 Nov 2021 | 100 | 1,956,186 (2%) | 0% | 98 | 9,800 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2021 | 23,923 | 711,612 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Guardant Health Inc | Helmy Eltoukhy | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 13 Aug 2021 | 23,923 | 1,851,686 (1%) | 0% | 4.2 | 99,998 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 160.12 per share. | 23 Apr 2021 | 7,388 | 1,828,514 (1%) | 0% | 160.1 | 1,182,993 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 160.01 per share. | 23 Apr 2021 | 751 | 1,827,763 (1%) | 0% | 160.0 | 120,167 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.76 per share. | 20 Apr 2021 | 23,879 | 1,837,275 (1%) | 0% | 152.8 | 3,647,866 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.80 per share. | 20 Apr 2021 | 18,150 | 1,861,154 (1%) | 0% | 151.8 | 2,755,090 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.30 per share. | 20 Apr 2021 | 7,677 | 1,894,428 (2%) | 0% | 151.3 | 1,161,551 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.93 per share. | 20 Apr 2021 | 5,556 | 1,879,304 (1%) | 0% | 150.9 | 838,543 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.11 per share. | 20 Apr 2021 | 3,900 | 1,884,860 (1%) | 0% | 149.1 | 581,540 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 150.27 per share. | 20 Apr 2021 | 3,752 | 1,902,105 (2%) | 0% | 150.3 | 563,796 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.35 per share. | 20 Apr 2021 | 3,500 | 1,888,760 (2%) | 0% | 148.4 | 519,232 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.11 per share. | 20 Apr 2021 | 2,168 | 1,892,260 (2%) | 0% | 152.1 | 329,771 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.10 per share. | 20 Apr 2021 | 1,711 | 1,906,556 (2%) | 0% | 148.1 | 253,402 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 153.25 per share. | 20 Apr 2021 | 1,373 | 1,835,902 (1%) | 0% | 153.3 | 210,419 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.47 per share. | 20 Apr 2021 | 699 | 1,905,857 (2%) | 0% | 149.5 | 104,480 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 159.08 per share. | 15 Apr 2021 | 64,664 | 2,039,213 (2%) | 0% | 159.1 | 10,286,626 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 158.38 per share. | 15 Apr 2021 | 43,845 | 2,103,877 (2%) | 0% | 158.4 | 6,944,158 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 158.70 per share. | 15 Apr 2021 | 33,093 | 1,959,299 (2%) | 0% | 158.7 | 5,251,823 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 160.31 per share. | 15 Apr 2021 | 27,191 | 2,012,022 (2%) | 0% | 160.3 | 4,358,899 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 153.03 per share. | 15 Apr 2021 | 22,280 | 1,918,242 (2%) | 0% | 153.0 | 3,409,562 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 157.12 per share. | 15 Apr 2021 | 13,465 | 2,147,722 (2%) | 0% | 157.1 | 2,115,560 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 158.01 per share. | 15 Apr 2021 | 11,156 | 1,992,392 (2%) | 0% | 158.0 | 1,762,795 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 151.17 per share. | 15 Apr 2021 | 10,122 | 1,949,077 (2%) | 0% | 151.2 | 1,530,096 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 152.01 per share. | 15 Apr 2021 | 8,555 | 1,940,522 (2%) | 0% | 152.0 | 1,300,468 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 157.09 per share. | 15 Apr 2021 | 6,774 | 2,003,548 (2%) | 0% | 157.1 | 1,064,143 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.67 per share. | 15 Apr 2021 | 6,242 | 2,161,187 (2%) | 0% | 156.7 | 977,947 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.00 per share. | 15 Apr 2021 | 4,594 | 1,908,934 (2%) | 0% | 156.0 | 716,663 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 155.29 per share. | 15 Apr 2021 | 2,901 | 1,913,528 (2%) | 0% | 155.3 | 450,491 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 153.91 per share. | 15 Apr 2021 | 1,813 | 1,916,429 (2%) | 0% | 153.9 | 279,046 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 161.12 per share. | 15 Apr 2021 | 1,700 | 2,010,322 (2%) | 0% | 161.1 | 273,905 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 156.80 per share. | 15 Apr 2021 | 667 | 1,908,267 (2%) | 0% | 156.8 | 104,588 | COMMON STOCK |
| Guardant Health Inc | Helmy Eltoukhy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 159.61 per share. | 15 Apr 2021 | 100 | 1,959,199 (2%) | 0% | 159.6 | 15,961 | COMMON STOCK |